Cyberounds Logo
October 23, 2019 | LOGIN | REGISTER | HELP | 
email a friend print Bookmark and Share
Beyond Insulin: Incretins and Glucose Regulation
CME credit is no longer available for this conference.
Sam Engel, M.D.

Dr. Engel is Clinical Professor of Medicine, Albert Einstein College of Medicine.

Within the past three years, Dr. Engel has received research support from and been on the Speaker's Bureau of Eli Lilly and Amylin.

This activity is made possible by an unrestricted educational grant from Amylin-Lilly.

Release Date: 07/20/2005
Termination Date: 07/20/2008

Estimated time to complete: 1 hour(s).

Albert Einstein College of Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Learning Objectives
Upon completion of this Cyberounds®, you should be able to:
  • Discuss the regulation of glucose homeostasis by incretins
  • Describe the abnormalities in incretin levels in Type 2 diabetes
  • Discuss the therapeutic approaches to restoring the incretin effect in Type 2 diabetes.

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
Please click below to accept the terms of this CME activity